Detalhe da pesquisa
1.
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.
Cancer
; 130(3): 421-432, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846845
2.
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.
Blood
; 139(21): 3148-3158, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303070
3.
Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.
Haematologica
; 109(2): 591-603, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534514
4.
Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Hematol Oncol
; 42(3): e3268, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676394
5.
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
Ann Hematol
; 103(4): 1305-1315, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049586
6.
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China.
Ann Hematol
; 103(6): 2073-2087, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581546
7.
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(4): 523-533, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247315
8.
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
Int J Cancer
; 153(5): 1016-1025, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204683
9.
Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma.
Invest New Drugs
; 41(4): 606-616, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37420136
10.
Long-term outcomes of relmacabtagene autoleucel in Chinese patients with relapsed/refractory large B-cell lymphoma: Updated results of the RELIANCE study.
Cytotherapy
; 25(5): 521-529, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36842849
11.
More accurate prediction of treatment response than mean apparent diffusion coefficient value in multiple myeloma using whole body MRI histogram analysis.
Future Oncol
; 19(17): 1175-1185, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386939
12.
A novel clinical immune-related prognostic model predicts the overall survival of mantle cell lymphoma.
Hematol Oncol
; 40(3): 343-355, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35368100
13.
Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
Ann Hematol
; 101(6): 1201-1210, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437610
14.
Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
AJR Am J Roentgenol
; 218(2): 310-319, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34523949
15.
Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
Age Ageing
; 51(1)2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673897
16.
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.
Br J Haematol
; 194(5): 862-869, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34328213
17.
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma.
Ann Hematol
; 99(6): 1331-1339, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382775
18.
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patients.
Eur J Haematol
; 105(3): 326-334, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32421883
19.
MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities.
Haematologica
; 109(5): 1619-1623, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235518
20.
Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial.
Haematologica
; 109(5): 1614-1618, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38205507